Improvements in moderate-to-severe hidradenitis suppurativa with upadacitinib: Results from a phase 2, randomized, placebo-controlled study

Authors

Institutions

Publication Details

Journal
Journal of the American Academy of Dermatology
Published
2025-02-04
DOI
https://doi.org/10.1016/j.jaad.2024.12.046
Citations
12
Primary Topic
Hidradenitis Suppurativa and Treatments
Type
article
Field-Weighted Citation Impact
24.06
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Improvements in moderate-to-severe hidradenitis suppurativa with upadacitinib: Results from a phase 2, randomized, placebo-controlled study

Heidi S. Camp, Scott Fretzin, Alexa B. Kimball, Bethanee J. Schlosser et al.
12 citations
Journal of the American Academy of Dermatology
Hidradenitis Suppurativa and Treatments
24.06
article

Improvements in moderate-to-severe hidradenitis suppurativa with upadacitinib: Results from a phase 2, randomized, placebo-controlled study

Heidi S. Camp, Scott Fretzin, Alexa B. Kimball, Bethanee J. Schlosser, Vimal H. Prajapati, Lindsay Ackerman, Tianyu Zhan, Xiaohong Huang, Hidetoshi Takahashi
article en
12 citations

Abstract

No abstract available for this paper.
Journal of the American Academy of DermatologyVol. 92(6)
AbbVie (United States) (US), Takayanagi Dental Clinic (JP)
Openalex Percentile: Top 0%
Hidradenitis Suppurativa and Treatments
24.06
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.